Juul plans to extend stay on FDA ban citing unevaluated evidence

Date: 2022-06-30   Author: Saipriya Iyer  Category: #market

Juul plans to extend stay on FDA ban citing unevaluated evidence

American electronic cigarette company Juul Labs Inc is reportedly trying to extend an interim stay on the Food and Drug Administration (FDA)’s ban on e-cigarettes.

In a court filing, Juul pointed out that the FDA disregarded over 6,000 pages of data provided regarding the aerosols produced by liquid heated in the pods which users eventually inhale.

Last week, the FDA stated that the market approval application sent by Juul provided conflicting or insufficient data about the possible dangers of using its products. This includes the potential leak of harmful chemicals from Juul pods.

But Juul believes that a more extensive FDA evaluation could have proven the absence of those harmful chemicals in the aerosols inhaled by Juul users.

The company also remarked that the FDA’s decision was influenced by immense political pressure. Even a temporary ban on Juul products would completely damage its brand image thereby favoring its competitors.

Over the past year, e-cigarette companies NJOY and British American Tobacco have received FDA approvals for their products. But the agency rejected some of their flavored products.

FDA stated that it approved the tobacco-flavored products of these companies as they proved to be beneficiary to adult smokers and exceeded the risk to underage users.

On the other hand, Juul has been seeking approval for its menthol-and tobacco-flavored pods and vaping devices. The company emphasized that none of its competitors were denied approval for similar reasons and the agency had no explanation for holding Juul to a separate standard.

The San Francisco-based vaping company was denied product authorization by FDA last Thursday and the agency informed Juul to immediately stop selling its products.

A day later, the Columbia Circuit Court of Appeals granted a stay over the FDA ban. The court is contemplating whether to permit Juul to sell its e-cigarettes and pods while it appeals the FDA’s decision.

Source credit:

https://www.cnbc.com/2022/06/28/juul-seeks-to-extend-stay-on-fda-ban-saying-agency-did-not-evaluate-all-its-evidence.html



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Scrutinizing Hesperetin market segmental trends over 2022-2028

Author: Sachin Pashte

The study on the global market for Hesperetin evaluates historical and current performance of this market, especially highlighting the key trends and growth opportunities. According to the study, the rising demand for this product is driving the g...


Herba Houttuyniae Extract market players to make profitable investments during 2022-2028

Author: Sachin Pashte

The latest research at Market Study Report on Herba Houttuyniae Extract Market provides a comprehensive analysis of the Herba Houttuyniae Extract market segments, including their dynamics, size, growth, regulatory requirements, technological trend...


Momordica Charantia Extract market to display unparalleled growth over 2022-2028

Author: Sachin Pashte

The demand for Global Momordica Charantia Extract market is anticipated to be high for the next five years. By considering this demand we provide latest Global Momordica Charantia Extract Market Report which gives complete industry analysis, marke...